Table 1 Haemoglobin levels, leukocyte and differential counts, and platelet counts between initial admission on 10 September and malaria treatment in early October, 2013
From: Vivax malaria in an Amazonian child with dilated cardiomyopathy
| Â | Haemoglobin (mmol/l) | Leukocytes (mm3) | Segmented neutrophils % | Lymphocytes % | Platelets (*109/l) | Important clinical events |
|---|---|---|---|---|---|---|
10/9 | 9.7 | 13,800 | 32 | 57 | 366 | Dyspnoea, starts Ceftriaxone |
12/9 | 9.7 | 7,900 | 45 | 49 | 292 | Â |
13/9 | 9.69 | 10,900 | 57 | 41 | 388 | Â |
13/9 | 10 | 14,900 | 48 | 46 | 370 | Â |
15/9 | 9.7 | 10,600 | 31 | 54 | 311 | Â |
23/9 | 9.5 | 32,200 | 70 | 16 | 299 | Diarrhoea since 17/9; starts Ceftazidime + Vancomycin |
26/9 | 9.5 | 9,500 | 53 | 36 | 320 | Â |
27/9 | 9.7 | 8,400 | 42 | 46 | 224 | Fever 38.5°C |
29/9 | 8.3 | 9,200 | 56 | 38 | 300 | Â |
3/10 | 6.6 | 12,100 | 53 | 13 | 102 | Blood transfusion after haemogram |
4/10 | 9.5 | 9,600 | 49 | 38 | 361 | Smear positive for P. vivax |
5/10 | 7.4 | 7,400 | 33 | 48 | 47 | Â |
6/10 | 7.7 | 14,800 | 32 | 48 | 79 | Â |